Schedule 13D ownership disclosure

ALPINE IMMUNE SCIENCES INC

Security class unavailable · CUSIP: 02083G100

Event date: 2021-11-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
14.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-21-001178
Form type
SC 13D/A
Filer
ALPINE IMMUNE SCIENCES, INC.
CIK
CIK 1626199
Filed
Nov 12, 2021
Reporting period
Nov 10, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub